Abiopharma

🔍 TURNER JOSEPH W (Executive)

Company: GREAT SOUTHERN BANCORP, INC. (GSBC)

Report Date: 2026-04-14

Detailed Transactions and Holdings:

• Acquired 6,000 shares of Common stock at $52.2 per share (Direct)
  Date: 2026-04-30 | Code: M | equity_swap_involved: false | shares_owned_after: 142,182.00 | transaction_form_type: 4
• Sold 6,000 shares of Common stock at $68.1603 per share (Direct)
  Date: 2026-04-30 | Code: S | equity_swap_involved: false | shares_owned_after: 136,182.00 | transaction_form_type: 4
• Acquired 17 shares of Common stock at $67.5743 per share (Direct)
  Date: 2026-04-14 | Code: J | equity_swap_involved: false | shares_owned_after: 11,395.00 | transaction_form_type: 5 | Footnotes: F1
• Holds 0 shares of Common stock (Direct)
  Date: 2026-04-14 | Code: H | nature_of_ownership: Spouse | shares_owned_after: 2,478.00
• Holds 0 shares of Common stock (Direct)
  Date: 2026-04-14 | Code: H | nature_of_ownership: 401(k) Plan | shares_owned_after: 18,563.00 | Footnotes: F2
• Holds 0 shares of Common stock (Direct)
  Date: 2026-04-14 | Code: H | nature_of_ownership: LTD Family Partnership | shares_owned_after: 369,738.00
• Sold 6,000 shares of Option to purchase at $52.2 per share (Derivative)
  Date: 2026-04-30 | Code: M | Expires: 2027-11-15 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F3
• Holds 7,000 shares of Option to purchase at $55.0 per share (Derivative)
  Date: 2026-04-14 | Code: H | Expires: 2028-11-28 | shares_owned_after: 7,000.00 | Footnotes: F4
• Holds 7,000 shares of Option to purchase at $60.15 per share (Derivative)
  Date: 2026-04-14 | Code: H | Expires: 2029-11-20 | shares_owned_after: 14,000.00 | Footnotes: F5
• Holds 7,500 shares of Option to purchase at $41.74 per share (Derivative)
  Date: 2026-04-14 | Code: H | Expires: 2030-10-26 | shares_owned_after: 21,500.00 | Footnotes: F6
• Holds 7,750 shares of Option to purchase at $57.98 per share (Derivative)
  Date: 2026-04-14 | Code: H | Expires: 2031-11-17 | shares_owned_after: 29,250.00 | Footnotes: F7
• Holds 7,800 shares of Option to purchase at $61.55 per share (Derivative)
  Date: 2026-04-14 | Code: H | Expires: 2032-11-16 | shares_owned_after: 37,050.00 | Footnotes: F8
• Holds 7,800 shares of Option to purchase at $53.22 per share (Derivative)
  Date: 2026-04-14 | Code: H | Expires: 2033-11-15 | shares_owned_after: 44,850.00 | Footnotes: F9
• Holds 7,800 shares of Option to purchase at $61.79 per share (Derivative)
  Date: 2026-04-14 | Code: H | Expires: 2034-11-20 | shares_owned_after: 52,650.00 | Footnotes: F10
• Holds 7,800 shares of Option to purchase at $57.29 per share (Derivative)
  Date: 2026-04-14 | Code: H | Expires: 2035-11-19 | shares_owned_after: 60,450.00 | Footnotes: F11

Footnotes:

• F1: DRIP acquisition exempt from Section 16 reporting being reported voluntarily
• F2: Reflects reporting person's holdings of units in Issuer's common stock fund under Issuer's 401(k) plan. Number of shares shown as beneficially owned under the plan represents the approximate equivalent number of shares of Issuer's common stock.
• F3: 1,500 shares vest on 11/15/2019, 11/15/2020, 11/15/2021 and 11/15/2022
• F4: 1,750 shares vest on 11/28/2020, 11/28/2021, 11/28/2022 and 11/28/2023
• F5: 1,750 shares vest on 11/20/2021, 11/20/2022, 11/20/2023 and 11/20/2024
• F6: 1,875 shares vest on 10/26/2022, 10/26/2023, 10/26/2024 and 10/26/2025
• F7: 1,938 shares vest on 11/17/2023 and 11/17/2024, and 1,937 shares vest on 11/17/2025 and 11/17/2026
• F8: 1,950 shares vest on 11/16/2024, 11/16/2025, 11/16/2026 and 11/16/2027
• F9: 1,950 shares vest on 11/15/2025, 11/15/2026, 11/15/2027 and 11/15/2028
• F10: 1,950 shares vest on 11/20/2026, 11/20/2027, 11/20/2028 and 11/20/2029
• F11: 1,950 shares vest on 11/19/2027, 11/19/2028, 11/19/2029 and 11/19/2030